David J. Rieman

3.2k total citations · 1 hit paper
35 papers, 2.5k citations indexed

About

David J. Rieman is a scholar working on Molecular Biology, Oncology and Rheumatology. According to data from OpenAlex, David J. Rieman has authored 35 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 15 papers in Oncology and 7 papers in Rheumatology. Recurrent topics in David J. Rieman's work include Cell Adhesion Molecules Research (7 papers), Bone Metabolism and Diseases (7 papers) and Bone health and treatments (5 papers). David J. Rieman is often cited by papers focused on Cell Adhesion Molecules Research (7 papers), Bone Metabolism and Diseases (7 papers) and Bone health and treatments (5 papers). David J. Rieman collaborates with scholars based in United States, Canada and United Kingdom. David J. Rieman's co-authors include Maxine Gowen, John C. Lee, Robert A. Dodds, Ian E. James, Russell Greig, Janice R. Connor, Fred H. Drake, Christine Debouck, Susan B. Richardson and Lindsay Coleman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Biochemical Journal.

In The Last Decade

David J. Rieman

35 papers receiving 2.4k citations

Hit Papers

Cathepsin K, but Not Cathepsins B, L, or S, Is Abundantly... 1996 2026 2006 2016 1996 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David J. Rieman United States 21 1.5k 862 488 418 385 35 2.5k
Edit Tarcsa United States 24 1.2k 0.8× 394 0.5× 141 0.3× 475 1.1× 329 0.9× 43 2.6k
T G Pretlow United States 23 1.1k 0.7× 615 0.7× 345 0.7× 241 0.6× 187 0.5× 56 2.7k
John G. Emery United States 16 1.4k 0.9× 611 0.7× 433 0.9× 702 1.7× 114 0.3× 20 2.0k
Ylermi Soini Finland 29 871 0.6× 615 0.7× 525 1.1× 137 0.3× 106 0.3× 44 2.3k
Marietta Armaka Greece 26 1.2k 0.8× 495 0.6× 378 0.8× 1.1k 2.6× 840 2.2× 36 2.8k
Shiro Ohshima Japan 23 809 0.5× 519 0.6× 189 0.4× 816 2.0× 835 2.2× 77 2.3k
Daniel Branstetter United States 21 1.0k 0.7× 808 0.9× 386 0.8× 387 0.9× 341 0.9× 40 2.0k
Takanori Eguchi Japan 31 2.1k 1.4× 413 0.5× 923 1.9× 260 0.6× 179 0.5× 79 2.8k
Claudio Celeghini Italy 26 1.3k 0.8× 497 0.6× 391 0.8× 621 1.5× 61 0.2× 73 2.3k
M Tohidast-Akrad Austria 18 1.4k 0.9× 851 1.0× 389 0.8× 491 1.2× 1.2k 3.2× 31 2.5k

Countries citing papers authored by David J. Rieman

Since Specialization
Citations

This map shows the geographic impact of David J. Rieman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Rieman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Rieman more than expected).

Fields of papers citing papers by David J. Rieman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Rieman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Rieman. The network helps show where David J. Rieman may publish in the future.

Co-authorship network of co-authors of David J. Rieman

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Rieman. A scholar is included among the top collaborators of David J. Rieman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Rieman. David J. Rieman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kumar, Sanjay, Charles R. Hanning, Michael Brigham‐Burke, et al.. (2002). INTERLEUKIN-1F7B (IL-1H4/IL-1F7) IS PROCESSED BY CASPASE-1 AND MATURE IL-1F7B BINDS TO THE IL-18 RECEPTOR BUT DOES NOT INDUCE IFN-γ PRODUCTION. Cytokine. 18(2). 61–71. 218 indexed citations
2.
Kumar, Sanjay, Bartholomew J. Votta, David J. Rieman, et al.. (2001). IL‐1‐ and TNF‐induced bone resorption is mediated by p38 mitogen activated protein kinase*. Journal of Cellular Physiology. 187(3). 294–303. 89 indexed citations
3.
Rieman, David J., Robert A. Dodds, Shing Mei Hwang, et al.. (2001). Biosynthesis and processing of cathepsin K in cultured human osteoclasts. Bone. 28(3). 282–289. 62 indexed citations
4.
Badger, Alison M., Don E. Griswold, Rasesh Kapadia, et al.. (2000). Disease-modifying activity of SB 242235, a selective inhibitor of p38 mitogen-activated protein kinase, in rat adjuvant-induced arthritis. Arthritis & Rheumatism. 43(1). 175–183. 186 indexed citations
5.
Prichett, William P., Amanda J. Patton, John G. Emery, et al.. (2000). Identification and cloning of a human urea transporter HUT11, which is downregulated during adipogenesis of explant cultures of human bone. Journal of Cellular Biochemistry. 76(4). 639–639. 1 indexed citations
6.
Kumar, Sanjay, Janice R. Connor, Robert A. Dodds, et al.. (1999). Identification and Cloning of a Connective Tissue Growth Factor-like cDNA from Human Osteoblasts Encoding a Novel Regulator of Osteoblast Functions. Journal of Biological Chemistry. 274(24). 17123–17131. 88 indexed citations
7.
Lark, Michael W., George B. Stroup, Shing Mei Hwang, et al.. (1999). Design and Characterization of Orally Active Arg-Gly-Asp Peptidomimetic Vitronectin Receptor Antagonist SB 265123 for Prevention of Bone Loss in Osteoporosis. Journal of Pharmacology and Experimental Therapeutics. 291(2). 612–617. 37 indexed citations
8.
Prabhakar, Uma, Ian E. James, Robert A. Dodds, et al.. (1998). A Novel Human Bone Marrow Stroma-Derived Cell Line TF274 Is Highly Osteogenic In Vitro and In Vivo. Calcified Tissue International. 63(3). 214–220. 21 indexed citations
9.
Keenan, Richard M., William H. Miller, M. Amparo Lago, et al.. (1998). Benzimidazole derivatives as arginine mimetics in 1,4-benzodiazepine nonpeptide vitronectin receptor (αvβ3) antagonists. Bioorganic & Medicinal Chemistry Letters. 8(22). 3165–3170. 18 indexed citations
10.
Kumar, Chandrika, Ian E. James, Angela Wong, et al.. (1997). Cloning and Characterization of a Novel Integrin β3Subunit. Journal of Biological Chemistry. 272(26). 16390–16397. 19 indexed citations
11.
Bradbeer, Jeremy N., Rasesh Kapadia, Susanta K. Sarkar, et al.. (1996). Disease‐modifying activity of SK&F 106615 in rat adjuvant‐induced arthritis. Multiparameter analysis of disease including magnetic resonance imaging and bone mineral density measurements. Arthritis & Rheumatism. 39(3). 504–514. 23 indexed citations
12.
Drake, Fred H., Robert A. Dodds, Ian E. James, et al.. (1996). Cathepsin K, but Not Cathepsins B, L, or S, Is Abundantly Expressed in Human Osteoclasts. Journal of Biological Chemistry. 271(21). 12511–12516. 590 indexed citations breakdown →
13.
Prabhakar, Uma, Ian E. James, Robert A. Dodds, et al.. (1995). In vitro mineralization of a novel human stromal cell line TF-274, correlates with its ability to form bone in vivo. Bone. 17(6). 571–571. 1 indexed citations
14.
Feild, John A., Robert H. Reid, David J. Rieman, et al.. (1992). Structure-function analysis of human transforming growth factor-α by site-directed mutagenesis. Biochemical Journal. 283(1). 91–98. 10 indexed citations
15.
Theodorescu, Dan, Derk J. Bergsma, Nabil A. Elshourbagy, et al.. (1991). Cloning and Overexpression of TGF-β1 cDNA in a Mammary Adenocarcinoma: In Vitro and In Vivo Effects. Growth Factors. 5(4). 305–316. 13 indexed citations
16.
Theodorescu, Dan, Madelyn M. Caltabiano, Russell Greig, David J. Rieman, & Robert S. Kerbel. (1991). Reduction of TGF‐beta activity abrogates growth promoting tumor cell‐cell interactions in vivo. Journal of Cellular Physiology. 148(3). 380–390. 24 indexed citations
17.
Murthy, Uma, David J. Rieman, & Ulrich Rodeck. (1990). Inhibition of TGFα-induced second messengers by anti-EGF receptor antibody-425. Biochemical and Biophysical Research Communications. 172(2). 471–476. 21 indexed citations
18.
Holden, Kenneth G., et al.. (1988). Synthesis and evaluation of multisubstrate inhibitors of an oncogene-encoded tyrosine-specific protein kinase. 1. Journal of Medicinal Chemistry. 31(9). 1762–1767. 15 indexed citations
19.
Holden, Kenneth G., Priscilla Offen, John A. Feild, et al.. (1988). Synthesis and evaluation of multisubstrate inhibitors of an oncogene-encoded tyrosine-specific protein kinase. 2. Journal of Medicinal Chemistry. 31(9). 1768–1772. 20 indexed citations
20.
Poste, George, Jeh-En Tzeng, J Doll, et al.. (1982). Evolution of tumor cell heterogeneity during progressive growth of individual lung metastases.. Proceedings of the National Academy of Sciences. 79(21). 6574–6578. 108 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026